1. Home
  2. GELS vs HBIO Comparison

GELS vs HBIO Comparison

Compare GELS & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GELS
  • HBIO
  • Stock Information
  • Founded
  • GELS 2018
  • HBIO 1901
  • Country
  • GELS Australia
  • HBIO United States
  • Employees
  • GELS N/A
  • HBIO N/A
  • Industry
  • GELS
  • HBIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • GELS
  • HBIO Industrials
  • Exchange
  • GELS NYSE
  • HBIO Nasdaq
  • Market Cap
  • GELS 15.9M
  • HBIO 15.3M
  • IPO Year
  • GELS 2024
  • HBIO 2000
  • Fundamental
  • Price
  • GELS $1.69
  • HBIO $0.41
  • Analyst Decision
  • GELS
  • HBIO Buy
  • Analyst Count
  • GELS 0
  • HBIO 2
  • Target Price
  • GELS N/A
  • HBIO $3.00
  • AVG Volume (30 Days)
  • GELS 85.2K
  • HBIO 34.9M
  • Earning Date
  • GELS 02-15-2025
  • HBIO 05-12-2025
  • Dividend Yield
  • GELS N/A
  • HBIO N/A
  • EPS Growth
  • GELS N/A
  • HBIO N/A
  • EPS
  • GELS N/A
  • HBIO N/A
  • Revenue
  • GELS $95,618.00
  • HBIO $91,397,000.00
  • Revenue This Year
  • GELS N/A
  • HBIO N/A
  • Revenue Next Year
  • GELS N/A
  • HBIO $9.75
  • P/E Ratio
  • GELS N/A
  • HBIO N/A
  • Revenue Growth
  • GELS N/A
  • HBIO N/A
  • 52 Week Low
  • GELS $0.77
  • HBIO $0.28
  • 52 Week High
  • GELS $5.50
  • HBIO $3.60
  • Technical
  • Relative Strength Index (RSI)
  • GELS N/A
  • HBIO 50.65
  • Support Level
  • GELS N/A
  • HBIO $0.37
  • Resistance Level
  • GELS N/A
  • HBIO $0.44
  • Average True Range (ATR)
  • GELS 0.00
  • HBIO 0.10
  • MACD
  • GELS 0.00
  • HBIO 0.01
  • Stochastic Oscillator
  • GELS 0.00
  • HBIO 19.24

About GELS GELTEQ LIMITED

Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

Share on Social Networks: